S
Stella Apostolaki
Researcher at University of Crete
Publications - 39
Citations - 2843
Stella Apostolaki is an academic researcher from University of Crete. The author has contributed to research in topics: Breast cancer & Circulating tumor cell. The author has an hindex of 23, co-authored 38 publications receiving 2699 citations.
Papers
More filters
Journal ArticleDOI
Molecular Detection of Cytokeratin-19–Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Significance
A. Stathopoulou,Ioannis G. Vlachonikolis,Dimitris Mavroudis,M. Perraki,Ch. Kouroussis,Stella Apostolaki,N. Malamos,S. Kakolyris,Athanasios Kotsakis,N. Xenidis,D Reppa,Vassilis Georgoulias +11 more
TL;DR: Molecular detection of CK-19 mRNA-positive cells by RT-PCR in the peripheral blood of patients with stages I and II breast cancer before initiation of adjuvant therapy has independent prognostic value as a marker of poor clinical outcome.
Journal ArticleDOI
Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 mRNA-Positive Cells Detected by Real-Time Polymerase Chain Reaction in Node-Negative Breast Cancer Patients
N. Xenidis,M. Perraki,Maria Kafousi,Stella Apostolaki,Irene Bolonaki,Aliki Stathopoulou,Kostas Kalbakis,Nikos Androulakis,Charalambos Kouroussis,Thanos Pallis,Charalambos Christophylakis,Katerina Argyraki,Evi Lianidou,Stathis Stathopoulos,Vassilis Georgoulias,Dimitris Mavroudis +15 more
TL;DR: In this paper, the authors evaluated the predictive and prognostic value of peripheral blood cytokeratin-19 (CK-19) mRNA-positive cells in axillary lymph node-negative breast cancer patients.
Journal ArticleDOI
Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer
Nikolaos Xenidis,Michail Ignatiadis,Stella Apostolaki,M. Perraki,Kostas Kalbakis,Sofia S. Agelaki,Efstathios N. Stathopoulos,Grigorios Chlouverakis,Evi Lianidou,S. Kakolyris,Vassilis Georgoulias,Dimitris Mavroudis +11 more
TL;DR: The detection of CK-19 mRNA-positive CTCs in the blood after adjuvant chemotherapy is an independent risk factor indicating the presence of chemotherapy-resistant residual disease.
Journal ArticleDOI
Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer
Michail Ignatiadis,Galatea Kallergi,Maria Ntoulia,M. Perraki,Stella Apostolaki,Maria Kafousi,Grigorios Chlouverakis,Efstathios N. Stathopoulos,Evi Lianidou,Vassilis Georgoulias,Dimitris Mavroudis +10 more
TL;DR: The detection of peripheral blood CK19mRNA+ and MGB1m RNA+ cells before adjuvant chemotherapy predicts poor DFS in women with early breast cancer.
Journal ArticleDOI
Different Prognostic Value of Cytokeratin-19 mRNA–Positive Circulating Tumor Cells According to Estrogen Receptor and HER2 Status in Early-Stage Breast Cancer
Michail Ignatiadis,N. Xenidis,M. Perraki,Stella Apostolaki,Eleni Politaki,Maria Kafousi,Efstathios N. Stathopoulos,Aliki Stathopoulou,Evi Lianidou,Grigorios Chlouverakis,Christos Sotiriou,Vassilis Georgoulias,Dimitris Mavroudis +12 more
TL;DR: In multivariate analysis, the interaction between CK-19 mRNA-positive CTCs and ER status was the strongest independent prognostic factor for reduced DFS and overall survival in patients with ER- negative, triple-negative, and HER2-positive early-stage breast cancer.